Dr Michael Kokott, DDS | |
1010 N Edge Trl, Verona, WI 53593-2026 | |
(608) 848-4000 | |
(608) 848-4022 |
Full Name | Dr Michael Kokott |
---|---|
Gender | Male |
Speciality | Dentist - General Practice |
Location | 1010 N Edge Trl, Verona, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801015151 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 3465WI (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Michael Kokott, DDS 1010 N Edge Trl, Verona, WI 53593-2026 Ph: (608) 848-4000 | Dr Michael Kokott, DDS 1010 N Edge Trl, Verona, WI 53593-2026 Ph: (608) 848-4000 |
News Archive
Tanabe Research Laboratories U.S.A. Inc., (TRL) announced today that it has entered into a partnership with Anaphore Inc. for the research and preclinical development of novel protein therapies for autoimmune diseases based on Anaphore's proprietary Atrimerâ„¢ technology.
There is insufficient evidence for the effectiveness of misoprostol in preventing postpartum hemorrhage, suggest findings from a review of available research published in the Journal of the Royal Society of Medicine.
Genzyme Corporation today reported four-year follow-up data from its completed Phase 2 multiple sclerosis (MS) trial showing an estimated 71 percent of alemtuzumab treated patients remain free of clinically-active disease as much as three years after most patients received their last course of the investigational compound. The data were presented at the American Academy of Neurology annual meeting.
Stem cells have huge potential in medicine because they have the ability to change or differentiate into many different cell types potentially providing a source of cells to replace those that have been permanently lost by a patient.
Researchers have discovered an enzyme crucial to a type of DNA repair that also causes resistance to a class of cancer drugs most commonly used against ovarian cancer.Scientists from The University of Texas MD Anderson Cancer Center and the Life Sciences Institute of Zhejiang University in China report the discovery of the enzyme and its role in repairing DNA damage called cross-linking in the Science Express advance online publication of Science.
› Verified 6 days ago
Dr. Austin Mathew Wessell, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 271 S Main St, Verona, WI 53593 Phone: 608-845-6612 | |
Dr. Dylan Charles Downs, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 925 N Main St, Verona, WI 53593 Phone: 608-848-2700 | |
Bradley Byce, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 927 N Main St, Verona, WI 53593 Phone: 608-227-7777 | |
Peter J Worman, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 927 N Main St, Verona, WI 53593 Phone: 608-227-7777 | |
Joseph Hugh Boysen, D.M.D Dentist Medicare: Not Enrolled in Medicare Practice Location: 925 N Main St, Verona, WI 53593 Phone: 608-848-0827 | |
Dr. Trent Logan Cox, DMD DHSC Dentist Medicare: Not Enrolled in Medicare Practice Location: 925 N Main St, Verona, WI 53593 Phone: 608-848-2700 | |
Daniel Joseph Wadzinski, DDS Dentist Medicare: Medicare Enrolled Practice Location: 109 East Verona Avenue, Verona, WI 53593 Phone: 608-845-6612 Fax: 608-845-8131 |